Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Mallinckrodt
UBS
Express Scripts
Federal Trade Commission
Baxter
Healthtrust
Novartis
QuintilesIMS

Generated: October 21, 2017

DrugPatentWatch Database Preview

Procainamide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for procainamide hydrochloride and what is the scope of procainamide hydrochloride freedom to operate?

Procainamide hydrochloride
is the generic ingredient in seven branded drugs marketed by Parke Davis, Watson Labs, Ivax Sub Teva Pharms, Parkedale, Ani Pharms Inc, Abraxis Pharm, Idt Australia Ltd, Pharmafair, Warner Chilcott, West-ward Pharms Int, Smith And Nephew, Solopak, Apothecon, Intl Medication, Hospira, Inwood Labs, Ascot, Lederle, Vangard, King Pharms, Panray, Sandoz, Roxane, and Lannett, and is included in sixty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for procainamide hydrochloride. Four suppliers are listed for this compound.

Summary for Generic Name: procainamide hydrochloride

US Patents:0
Tradenames:7
Applicants:24
NDAs:69
Drug Master File Entries: see list8
Suppliers / Packagers: see list4
Bulk Api Vendors: see list55
Clinical Trials: see list2,297
Patent Applications: see list1,554
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:procainamide hydrochloride at DailyMed

Pharmacology for Ingredient: procainamide hydrochloride

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL084604-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vangard
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL087643-001Jun 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL084696-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL084403-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL083287-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Idt Australia Ltd
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL089369-003Aug 14, 1987RXNoNo► Subscribe► Subscribe► Subscribe
Smith And Nephew
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
INJECTABLE;INJECTION088531-001Mar 4, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL089026-001Oct 22, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Inwood Labs
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL089840-001Mar 6, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL084280-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: procainamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms
PROCANBID
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL020545-002Jan 31, 1996► Subscribe► Subscribe
King Pharms
PROCANBID
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL020545-001Jan 31, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Cipla
Cerilliant
Dow
US Department of Justice
Novartis
Chinese Patent Office
US Army
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot